Sign up Australia
Proactive Investors - Run By Investors For Investors

Amryt Pharma agrees Lojuxta distribution deal for Romania and Bulgaria

Dave Allmond, chief commercial officer at Amryt Pharma PLC (LON:AMYT), discusses with Proactive their fourth distribution deal signed in three months for Lojuxta.

Lojuxta treats a very rare, life-threatening genetic condition which causes “bad cholesterol” to accumulate in the body. 

This latest agreement, covering Romania and Bulgaria, is with Romastru Trading, part of the Pharaon Healthcare Europe conglomerate.

 
Meet Great Boulder Resources Ltd, High Peak Royalties Ltd, Blackstone Minerals Ltd, Yandal Resources Ltd and Red River Resources Ltd at our event, Melbourne , 20 November 2018. Register here »
View full AMYT profile View Profile

Amryt Pharma PLC Timeline

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use